Prio Wealth Limited Partnership Eli Lilly & CO Transaction History

Prio Wealth Limited Partnership

$3.32 Billion
Q2 2024

A detailed history of Prio Wealth Limited Partnership transactions in Eli Lilly & CO stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 2,400 shares of LLY stock, worth $2.22 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,747 12.63%

Holding current value

$2.22 Million

Previous $2.14 Million 1.64%

% of portfolio

0.07%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 10, 2024	SELL	$724.87 - $909.04 $251,529 - $315,436	-347 Reduced 12.63%	2,400 $2.17 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $254,053 - $339,888	429 Added 18.51%	2,747 $2.14 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $14,779 - $20,376	-34 Reduced 1.45%	2,318 $1.25 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $59,625 - $79,726	170 Added 7.79%	2,352 $1.1 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $107,477 - $126,227	-346 Reduced 13.69%	2,182 $749,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $45,981 - $53,577	-143 Reduced 5.35%	2,528 $0
Q3 2022 Feb 27, 2023	BUY	$296.48 - $337.87 $32,316 - $36,827	109 Added 4.3%	2,646 $855,000
Q2 2022 Feb 27, 2023	BUY	$278.73 - $327.27 $2,508 - $2,945	9 Added 0.36%	2,537 $822,000
Q1 2022 Feb 21, 2023	BUY	$234.69 - $291.66 $31,448 - $39,082	134 Added 5.3%	2,662 $762,000
Q4 2021 Feb 17, 2022	SELL	$224.85 - $279.04 $24,058 - $29,857	-107 Reduced 3.85%	2,671 $738,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $6,648 - $8,181	-30 Reduced 1.07%	2,778 $642,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $24,193 - $31,294	-134 Reduced 4.55%	2,808 $644,000
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $118,803 - $153,796	-723 Reduced 19.73%	2,942 $550,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $17,481 - $23,132	134 Added 3.79%	3,665 $619,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $36,555 - $42,282	-250 Reduced 6.61%	3,531 $523,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $109,135 - $131,344	-800 Reduced 17.46%	3,781 $621,000
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $41,667 - $51,572	-350 Reduced 7.1%	4,581 $635,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $34,855 - $43,172	326 Added 7.08%	4,931 $648,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $36,949 - $40,191	-346 Reduced 6.99%	4,605 $515,000
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $2,769 - $3,233	-25 Reduced 0.5%	4,951 $548,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $29,497 - $34,720	-265 Reduced 5.06%	4,976 $645,000
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $1,545 - $1,931	18 Added 0.34%	5,241 $562,000
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $529 - $608	7 Added 0.13%	5,223 $445,000
Q1 2018 Apr 17, 2018	BUY	$74.21 - $87.6 $387,079 - $456,921	5,216 New	5,216 $403,000

Others Institutions Holding LLY

# of Institutions

3,868

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $878B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Account

Prio Wealth Limited Partnership Eli Lilly & CO Transaction History